arsenic trioxide has been researched along with andrographolide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haghighatnazar, S; Safaeian, L; Shafiee, F | 1 |
1 other study(ies) available for arsenic trioxide and andrographolide
| Article | Year |
|---|---|
Andrographolide protects against doxorubicin-and arsenic trioxide-induced toxicity in cardiomyocytes.
Topics: Antioxidants; Apoptosis; Arsenic Trioxide; Cell Line; Diterpenes; Doxorubicin; Myocytes, Cardiac; Oxidants; Oxidative Stress; Reactive Oxygen Species; Toll-Like Receptor 4 | 2023 |